These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24721670)
1. Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients. Song Y; Ding H; Yang J; Lin Q; Xue J; Zhang Y; Chan P; Cai Y Neurosci Lett; 2014 May; 569():85-8. PubMed ID: 24721670 [TBL] [Abstract][Full Text] [Related]
2. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients. Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085 [TBL] [Abstract][Full Text] [Related]
3. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro. Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746 [TBL] [Abstract][Full Text] [Related]
4. SNCA Hypomethylation in Rapid Eye Movement Sleep Behavior Disorder Is a Potential Biomarker for Parkinson's Disease. Zhao A; Li Y; Niu M; Li G; Luo N; Zhou L; Kang W; Liu J J Parkinsons Dis; 2020; 10(3):1023-1031. PubMed ID: 32444558 [TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease. Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies. Funahashi Y; Yoshino Y; Yamazaki K; Mori Y; Mori T; Ozaki Y; Sao T; Ochi S; Iga JI; Ueno SI Psychiatry Clin Neurosci; 2017 Jan; 71(1):28-35. PubMed ID: 27685250 [TBL] [Abstract][Full Text] [Related]
7. Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients. Mao W; Zhao C; Ding H; Liang K; Xue J; Chan P; Cai Y Neurosci Lett; 2018 Mar; 668():115-119. PubMed ID: 29353016 [TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease. Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201 [TBL] [Abstract][Full Text] [Related]
9. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. Matsumoto L; Takuma H; Tamaoka A; Kurisaki H; Date H; Tsuji S; Iwata A PLoS One; 2010 Nov; 5(11):e15522. PubMed ID: 21124796 [TBL] [Abstract][Full Text] [Related]
10. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation levels of α-synuclein intron 1 in the aging brain. de Boni L; Riedel L; Schmitt I; Kraus TFJ; Kaut O; Piston D; Akbarian S; Wüllner U Neurobiol Aging; 2015 Dec; 36(12):3334.e7-3334.e11. PubMed ID: 26422361 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease correlates with promoter methylation in the α-synuclein gene. Pihlstrøm L; Berge V; Rengmark A; Toft M Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759 [TBL] [Abstract][Full Text] [Related]
13. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability. Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the α-synuclein gene in human brain tissue. Brenner S; Wersinger C; Gasser T Neurosci Lett; 2015 Jul; 599():140-5. PubMed ID: 26002080 [TBL] [Abstract][Full Text] [Related]
17. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. Jowaed A; Schmitt I; Kaut O; Wüllner U J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061 [TBL] [Abstract][Full Text] [Related]
18. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population. Wei Y; Yang N; Xu Q; Sun Q; Guo J; Li K; Liu Z; Yan X; Zhu X; Tang B J Neurol Sci; 2016 Aug; 367():11-4. PubMed ID: 27423554 [TBL] [Abstract][Full Text] [Related]
19. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Ally MS; Al-Ghnaniem R; Pufulete M Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481 [TBL] [Abstract][Full Text] [Related]
20. DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with Smith AR; Richards DM; Lunnon K; Schapira AHV; Migdalska-Richards A Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]